Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Carole Ho

Tracked across 2 events · 31 articles · First seen Jul 16, 2026 · Last active Sep 11, 2026

Sentiment
2
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 5
Business
Eli Lilly and Company announced on September 11, 2026 the successful completion of its acquisition of Atai Life Sciences, a clinical-stage biopharmaceutical company developing rapid-acting neuroplastogens for mental health conditions. AtaiBeckley's lead investigational program, BPL-003,…
Impact: Carole Ho, Lilly executive vice president and president of Lilly Neuroscience, publicly commented on the strategic rationale of the acquisition and the potential of AtaiBeckley's neuroplastogens.
Sep 11, 2026 · 6 articles
4 0
Business
Impact: Carole Ho, Executive Vice President and President of Lilly Neuroscience, commented on the acquisition, emphasizing the need for effective treatments for treatment-resistant depression.
Jul 16, 2026 · 25 articles
ERGEN INTELLIGENCE
Track Carole Ho live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.